Skip to content
MedsAcross

Brand family

Intuniv

Guanfacine · Takeda Pharmaceuticals
United States
Presentations
4
Markets
1

Intuniv is a brand of Guanfacine marketed by Takeda Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Guanfacine
Brand owner
Takeda Pharmaceuticals
Registered in
United States
Strengths and forms
1 mg extended-release tablet, 2 mg extended-release tablet, 3 mg extended-release tablet, 4 mg extended-release tablet

All presentations

MedicineManufacturerRegisterAvailability
Intuniv 1 mg extended-release tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Intuniv 2 mg extended-release tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Intuniv 3 mg extended-release tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Intuniv 4 mg extended-release tabletOralTakeda PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Intuniv

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.